Journal of Nanomedicine & Biotherapeutic Discovery

Journal of Nanomedicine & Biotherapeutic Discovery
Open Access

ISSN: 2155-983X

+44 1300 500008

Sergey Bachurin

Sergey Bachurin

Human Bioenergetics and Applied Health Science, Bethel University, Minnesota, United States

He has received her PhD degree in Biochemistry from the University of Texas at Austin. After Post-doctoral training at NIH and Washington University School of Medicine, and briefly joining the Research faculty at University of Minnesota, she founded MicroSurfaces, Inc. and has served as its CEO since. She was a member on several NIH study sessions, author of 30 scientific papers and patents, and PI on multiple SBIR awards from NIH and NSF. She has been responsible for the development and launch of MicroSurfaces’ product lines, e.g. the ZeroBkg® surfaces, Fluid Array surfaces, etc. to serve the biomedical research community.
Research Interest

Drug design and Drug discovery. Medicinal chemistry of neurodegenerative disorders, in particular, Alzheimers disease, Parkinsons disease. Mechanism-based search for new medicines for neurological disorders, in particular, neuroprotectors and cognition-enhancers. Experimental models of neurological disorders. Novel drug-delivery system, in particular synthetic nanosized particles as a drug-delivery agents.

Relevant Topics